Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia.
Sordo-Bahamonde C, Lorenzo-Herrero S, Martínez-Pérez A, Gonzalez-Rodriguez AP, Payer ÁR, González-García E, Aguilar-García C, González-Rodríguez S, López-Soto A, García-Torre A, Gonzalez S. Sordo-Bahamonde C, et al. Among authors: payer ar. Cancer Immunol Immunother. 2023 Jul;72(7):2529-2539. doi: 10.1007/s00262-023-03435-1. Epub 2023 Apr 11. Cancer Immunol Immunother. 2023. PMID: 37041226 Free PMC article.
Lenalidomide and chronic lymphocytic leukemia.
González-Rodríguez AP, Payer AR, Acebes-Huerta A, Huergo-Zapico L, Villa-Alvarez M, Gonzalez-García E, Gonzalez S. González-Rodríguez AP, et al. Among authors: payer ar. Biomed Res Int. 2013;2013:932010. doi: 10.1155/2013/932010. Epub 2013 Sep 19. Biomed Res Int. 2013. PMID: 24163824 Free PMC article. Review.
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia. Correlation with progressive disease.
Huergo-Zapico L, Acebes-Huerta A, Gonzalez-Rodriguez AP, Contesti J, Gonzalez-García E, Payer AR, Villa-Alvarez M, Fernández-Guizán A, López-Soto A, Gonzalez S. Huergo-Zapico L, et al. Among authors: payer ar. PLoS One. 2014 Oct 6;9(10):e108326. doi: 10.1371/journal.pone.0108326. eCollection 2014. PLoS One. 2014. PMID: 25286418 Free PMC article.
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy.
Fernandez-Alvarez R, Gonzalez-Rodriguez AP, Gonzalez ME, Rubio-Castro A, Dominguez-Iglesias F, Solano J, Alonso-Nogues E, Fernandez-Alvarez C, Zanabili Y, Alonso JM, Payer AR, Vicente JM, Medina J, Sancho JM. Fernandez-Alvarez R, et al. Among authors: payer ar. Leuk Lymphoma. 2015;56(11):3096-102. doi: 10.3109/10428194.2015.1038709. Epub 2015 May 12. Leuk Lymphoma. 2015. PMID: 25860241
On the prediction of Hodgkin lymphoma treatment response.
deAndrés-Galiana EJ, Fernández-Martínez JL, Luaces O, Del Coz JJ, Fernández R, Solano J, Nogués EA, Zanabilli Y, Alonso JM, Payer AR, Vicente JM, Medina J, Taboada F, Vargas M, Alarcón C, Morán M, González-Ordóñez A, Palicio MA, Ortiz S, Chamorro C, Gonzalez S, González-Rodríguez AP. deAndrés-Galiana EJ, et al. Among authors: payer ar. Clin Transl Oncol. 2015 Aug;17(8):612-9. doi: 10.1007/s12094-015-1285-z. Epub 2015 Apr 21. Clin Transl Oncol. 2015. PMID: 25895906
Bortezomib plus CHOP for the treatment of HIV-associated plasmablastic lymphoma: clinical experience in three patients.
Fernandez-Alvarez R, Gonzalez-Rodriguez AP, Rubio-Castro A, Gonzalez ME, Payer AR, Alonso-Garcia A, Rodriguez-Villar D, Dominguez-Iglesias F, Sancho JM. Fernandez-Alvarez R, et al. Among authors: payer ar. Leuk Lymphoma. 2016 Feb;57(2):463-466. doi: 10.3109/10428194.2015.1050666. Epub 2015 Jun 18. Leuk Lymphoma. 2016. PMID: 25976108 No abstract available.
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia.
Villa-Álvarez M, Lorenzo-Herrero S, Gonzalez-Rodriguez AP, López-Soto A, Payer AR, Gonzalez-Garcia E, Huergo-Zapico L, Gonzalez S. Villa-Álvarez M, et al. Among authors: payer ar. Oncoimmunology. 2017 Jul 20;6(10):e1353856. doi: 10.1080/2162402X.2017.1353856. eCollection 2017. Oncoimmunology. 2017. PMID: 29123965 Free PMC article.
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling.
Lorenzo-Herrero S, Sordo-Bahamonde C, Bretones G, Payer ÁR, González-Rodríguez AP, González-García E, Pérez-Escuredo J, Villa-Álvarez M, Núñez LE, Morís F, Gonzalez S, López-Soto A. Lorenzo-Herrero S, et al. Among authors: payer ar. Front Immunol. 2019 Oct 18;10:2455. doi: 10.3389/fimmu.2019.02455. eCollection 2019. Front Immunol. 2019. PMID: 31681329 Free PMC article.
31 results